Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more)
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Acasti Pharma Inc
ACST
Healthcare
Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the...
brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ACST)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(1954)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 24, 2020 9:12am
RE:Upon Further Review
Maybe the doctors blew it and did not wait 6 weeks between time of screening and time of randomization...... Inclusion Criteria: Subjects ≥18 years of age. Isolated
...more
(63)
•••
hydrocarbss
X
View Profile
View Bullboard History
Post by
hydrocarbss
on Jun 24, 2020 8:52am
Upon Further Review
Feb 10 PR PDF File Conducting a clinical trial: The FDA has detailed and exhaustive guidelines for drug companies to use in crafting clinical trial procedures. The Investigators
...more
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine
posted May 16, 2024 9:00am by
Northstar Gold Corp.
-
|
Large 350m, 200 Siemens near-surface EM conductor defines possible southeast strike extension of Cam Copper Zone 2 (14.8% copper over 2.5 metres in DDH CC03-23) indicating possible massive sulphide mineralization along strike and similar in composition to Cam Copper Mine Zone 2 but with potentially greater thickness ...read more
(61)
•••
WalkOverTheStrt
X
View Profile
View Bullboard History
Comment by
WalkOverTheStrt
on Jun 23, 2020 10:38pm
RE:RE:RE:RE:Help with terminology - appreciated
@Danny but the placebo effect was more than at those 5 sites, just had a strong presence more than at other sites...
(61)
•••
WalkOverTheStrt
X
View Profile
View Bullboard History
Comment by
WalkOverTheStrt
on Jun 23, 2020 9:54pm
RE:Open for Answers
If mgmt does not make it clear the probability / or give context how the 5 sites placebos failed and give SHs comfort it will not be repeated at more sites beyond the five (as pointed out by a
...more
(18)
•••
EternalPonzi
X
View Profile
View Bullboard History
Comment by
EternalPonzi
on Jun 23, 2020 3:40pm
RE:RE:RE:RE:RE:Open for Answers
Management's candor has been sorely lacking. Self-interest will dictate their actions not fudiciary responsibility. I hope for the best, for everyone's sake and their stake, but expect
...more
(52)
•••
Francine01
X
View Profile
View Bullboard History
Comment by
Francine01
on Jun 23, 2020 12:20pm
RE:RE:RE:RE:Open for Answers
I don't agree. the only relevant important information that will be disclose is what was the active ingredient in the placebo / 5 sites arm. The rest is irrelevant. because the only thing which
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Post by
Rosmorduc
on Jun 23, 2020 12:18pm
I hope management doesn't screw things up again
Their record of messing things up has been stellar. A 20 year old would run the company better than Jan.
(13)
•••
Danny1082Man
X
View Profile
View Bullboard History
Comment by
Danny1082Man
on Jun 23, 2020 12:11pm
RE:RE:RE:Open for Answers
I agree with your post. However the June 29th call will be critical to see if Acasti is transparent or just covering up failure for T2. All the DD I have done points to a successful T2 considering the
...more
(52)
•••
Francine01
X
View Profile
View Bullboard History
Comment by
Francine01
on Jun 23, 2020 11:11am
RE:RE:Open for Answers
Why selling when nobody knows or understand the situation!? I am reading all the "shorts" on this board who want to make a quick buck before next monday conf call. They like to spread that
...more
(51)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Jun 23, 2020 5:06am
RE:Open for Answers
Can anybody tell me why the share price has not tanked ? Or do people still think there will be a way forward?
(13)
•••
Danny1082Man
X
View Profile
View Bullboard History
Post by
Danny1082Man
on Jun 22, 2020 9:52pm
Open for Answers
Why a Monday 1pm call? If it were just an earnings call who cares, they have no earnings. With their commitment to share a "detailed audit update" you would think there is material info
...more
(13)
•••
Danny1082Man
X
View Profile
View Bullboard History
Comment by
Danny1082Man
on Jun 22, 2020 7:52pm
RE:RE:RE:RE:RE:TRILOGY 2
Ferridan, Absolutely if we get transparent audit it sheds a blaring spotlight on the potential success of T2. We deserve clear data points on all T1 patients. What sites had placebo in it, how many at
...more
(61)
•••
WalkOverTheStrt
X
View Profile
View Bullboard History
Comment by
WalkOverTheStrt
on Jun 22, 2020 7:50pm
RE:RE:RE:TRILOGY 2
QT good catch and this aspect makes me even more weary to hold my shares... At one point the PPS approached $1 whcih is my breakeven and I didn't pull the trigger. Then again i didn't pull the
...more
(61)
•••
WalkOverTheStrt
X
View Profile
View Bullboard History
Comment by
WalkOverTheStrt
on Jun 22, 2020 7:47pm
RE:RE:RE:RE:RE:TRILOGY 2
Francine - Agree too soon to report T2 results, I am guessing end of July / early Aug. Also spot on that FDA did not agree with removing T1 5 sites. Surprised with how many here are trying to
...more
(7)
•••
ferraridan
X
View Profile
View Bullboard History
Comment by
ferraridan
on Jun 22, 2020 6:22pm
RE:RE:RE:RE:TRILOGY 2
Francine: I don't agree saying it will be end of speculation on June 29. To recap: - The FDA did not allow modified statistical plan to remove the 5 sites so in that sense we did waste our
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
IAMGOLD Reports First Quarter 2024 Results
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition